港股異動 | 信義光能(0968.HK)七連跌 股價年內腰斬 機構紛紛大砍目標價
格隆匯5月7日丨信義光能(0968.HK)跌逾8%,暫錄七連跌,報10.16港元,股價創去年9月份以來新低,相較於今年1月初創下的歷史高點24.8港元,股價已經累計跌去逾59%,最新總市值895億港元。花旗發佈最新研究報吿,將信義光能目標價由15港元降23.3%至11.5港元, 重申“中性”評級。該行下調公司2021-23年淨利潤預測18%至51%,以反映光伏玻璃售價下降。目前2021年預測市盈率19.4倍及市帳率3.5倍,高於歷史平均水平54%及35%。瑞信降信義光能目標價至19港元,維持跑贏大市評級;大和則將其目標價降至11.5港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.